Regarding the incidence of cutaneous malignancies, we diagnosed an in situ melanoma in only one patient with a BRCA2 mutation, while another BRCA2 mutation carrier reported a positive familiar history for melanoma in his sister, that died due to melanoma, carryingBRCA2 mutation too. This evidence concerns the gene BRCA2 and melanoma.